Mark K. Su
Impact in
- Toxicology top 0.5%
- Forensic Toxicology and Drug Analysis
- Emergency Medicine top 2%
- Poisoning and overdose treatments
Papers in
-
- Poisoning and overdose treatments 16
-
- Drug-Induced Hepatotoxicity and Protection 6
- Cannabis and Cannabinoid Research 4
- Antibiotics Pharmacokinetics and Efficacy 2
- Co-authors
- Robert S. Hoffman (24 shared papers)Joseph J. Palamar (3 shared papers)Danielle C. Ompad (1 shared paper)Jason Chu (4 shared papers)Sílvia S. Martins (1 shared paper)Theodore C. Bania (2 shared papers)In‐Hei Hahn (2 shared papers)Jeanna M. Marraffa (5 shared papers)
- Journals
- Clinical Toxicology (14 papers)Journal of Medical Toxicology (13 papers)Academic Emergency Medicine (6 papers)The American Journal of Emergency Medicine (3 papers)Journal of Vision (3 papers)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Mark K. Su
61 papers receiving 841 citations
Peers
Comparison fields: 5 of 106
- Toxicology 244
- Emergency Medicine 176
- Pharmacology 173
- Pharmacology 63
- Clinical Psychology 148
Countries citing papers authored by Mark K. Su
This map shows the geographic impact of Mark K. Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark K. Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark K. Su more than expected).
Fields of papers citing papers by Mark K. Su
This network shows the impact of papers produced by Mark K. Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark K. Su. The network helps show where Mark K. Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark K. Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 132 | |
| 2 | 2007 | 104 | |
| 3 | 2013 | 95 | |
| 4 | 2015 | 54 | |
| 5 | 2007 | 50 | |
| 6 | 2019 | 42 | |
| 7 | 2020 | 35 | |
| 8 | 2016 | 29 | |
| 9 | 2015 | 27 | |
| 10 | 2013 | 25 | |
| 11 | 2001 | 25 | |
| 12 | 2020 | 25 | |
| 13 | 2010 | 23 | |
| 14 | 2002 | 20 | |
| 15 | 2018 | 19 | |
| 16 | 2018 | 18 | |
| 17 | 2016 | 14 | |
| 18 | 2024 | 13 | |
| 19 | 2018 | 13 | |
| 20 | 2003 | 10 |
About Mark K. Su
Mark K. Su is a scholar working on Emergency Medicine, Pharmacology, Toxicology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 78 papers that have together received 907 indexed citations. Recurring topics across this work include Poisoning and overdose treatments (16 papers), Forensic Toxicology and Drug Analysis (7 papers), Drug-Induced Hepatotoxicity and Protection (6 papers), Cannabis and Cannabinoid Research (4 papers), Alcoholism and Thiamine Deficiency (3 papers), Alcohol Consumption and Health Effects (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Drug-Induced Ocular Toxicity (2 papers). The work is most often cited by research in Toxicology (244 citations), Emergency Medicine (176 citations), Pharmacology (173 citations), Pharmacology (63 citations) and Clinical Psychology (148 citations). Mark K. Su has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Robert S. Hoffman, Joseph J. Palamar, Danielle C. Ompad, Jason Chu, Sílvia S. Martins, Theodore C. Bania, In‐Hei Hahn, Jeanna M. Marraffa, Mary Ann Howland and Nicholas Nacca. Their work appears in journals such as Clinical Toxicology, Journal of Medical Toxicology, Academic Emergency Medicine, The American Journal of Emergency Medicine and Journal of Vision.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.